Overview

This volume examines the various issues in access to health issues and the role of intellectual property rights in access to drugs and the scope for using traditional medicine in public health. A team of experts from China, India, UK, Germany, The Netherlands, Norway and the Philippines have contributed to this volume. The volume examines Health Impact Fund, a mechanism that is proposed to incentivise R&D in neglected diseases and enhance access to drugs, and analyses how China and India can cooperate in traditional medicine sector besides providing reviews on the status of traditional medicine in both countries and the challenges before that sector in China and India in regulation, intellectual property rights and industrial policy. This is a unique volume that makes a significant contribution to the debates on access to medicine and role of traditional medicine in public health.

Full Product Details

Author:   Sachin Chaturvedi ,  Miltos Ladikas ,  Guo Lifeng ,  Krishna Ravi Srinivas
Publisher:   Academic Foundation
Imprint:   Academic Foundation
Weight:   0.456kg
ISBN:  

9789332700833

ISBN 10:   9332700834
Pages:   364
Publication Date:   30 August 2014
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Foreword A.P.J. Abdul Kalam Preface Biswajit Dhar Introduction Health Sector Challenges, Traditional Medicines and India China Collaboration Section I: Health Impact Fund 1. The Health Impact Fund: Issues and Challenges 2. Stakeholder Views Regarding the Objectives and Implementation of the HIF 3. Health Impact of New Pharmaceutical Pro-ducts in the Context of Health Impact Funds 4. Gender-based Barriers to Access to Health Care and Medicine: The Case of India and China Section II: India 5. Intellectual Property Rights and Traditional Chinese Medicine: The Experience in China and What India can learn from that 6. Dynamics of Traditional Medicine Industry: Issues in Trade, Technology and Standards 7. Regulatory Guidelines for Traditional Medicines in India 8. Traditional Medicine and Intellectual Property Policies Section III: China 9. China-India Cooperation on Intellectual Property Protection of Traditional Medicines 10. Industrial Development: External Trade and R&D of Traditional Chinese Medicine 11. Traditional Drug: Standard and Basic Medicine System of China 12. Public Health Problem and Development of Traditional Medicine Section IV: Conclusion 13. Potential or China-India Cooperation and HIF: Concluding Remarks and Policy Recommendations

Reviews

This timely and much-needed volume offers innovative responses to global health inequalities and the contemporary global intellectual property regime by examining the experiences of two countries that are deeply engaged in these areas, India and China. Innovative alternatives to the current global patent system are proposed including ways to employ Indian and Chinese medical systems to fill the gap in access to essential treatments. This should be required reading for anyone concerned about the future of global public health. --Murphy Halliburton, PhD, associate professor, department of anthropology, Queens College, and the Graduate Center, City University of New York

Author Information

Sachin Chaturvedi is a Senior Fellow at the Research and Information System for Developing Countries (RIS), a think tank with the Government of India’s Ministry of External Affairs. He works on, inter alia, development cooperation policies and South-South cooperation, and science, technology and innovation policies. Miltos Ladikas currently holds Research Fellow posts at the Centre for Professional Ethics, University of Central Lancashire, UK and the Institute for Technology Assessment and Systems Analysis, Karlsruhe Institute of Technology, Germany. His professional background covers the areas of technology assessment, public perceptions of S&T, ethics in S&T policy and science and development. Guo Lifeng is Associate Professor, Chinese Academy of Science and Technology for Development (CASTED), Ministry of Science and Technology, Beijing, China. Her research interests include science and technology polices and IPR issue in International trade. Krishna Ravi Srinivas is an Associate Fellow with RIS, a policy research think tank based in New Delhi, India. He has written on, inter alia, IPRs, open source and open innovation models, traditional knowledge, and climate change and technology transfer.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions